Finally,blockade of the mTOR cascade reduced hyperglycemic damage also in a morepathophysiologically relevant model, i.e. in human umbilical veinendothelial cells (HUVEC) exposed to hyperglycemia. This evidence concerns the gene MTOR and Hyperglycemia.